Pages that link to "Q71571103"

The following pages link to Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation (Q71571103):

Displaying 14 items.

• High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment (Q31043227) (← links)
• Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia (Q33886052) (← links)
• Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens (Q34107884) (← links)
• Flow Cytometry and Polymerase Chain Reaction-Based Analyses of Minimal Residual Disease in Chronic Lymphocytic Leukemia (Q34155701) (← links)
• New Directions in the Diagnosis and Treatment of Chronic Lymphocytic Leukaemia (Q35109116) (← links)
• Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia (Q35848136) (← links)
• Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure? (Q36292975) (← links)
• Transplantation in chronic lymphocytic leukemia (Q37738522) (← links)
• Eradicating minimal residual disease in chronic lymphocytic leukemia: should this be the goal of treatment? (Q37738532) (← links)
• Clonality and phenotyping of canine lymphomas before chemotherapy and during remission using polymerase chain reaction (PCR) on lymph node cytologic smears and peripheral blood (Q42045015) (← links)
• Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis. (Q48333236) (← links)
• PCR-based clonality assessment in patients with lymphocytic leukaemias: a single-institution experience. (Q54445657) (← links)
• Chronic lymphatic leukemia and hairy cell leukemia. Diagnosis and therapy (Q73696989) (← links)
• Use of alemtuzumab and rituximab consolidation in CLL: Pros and cons (Q84122212) (← links)